According to BioNTech, the Covid vaccine is effective against important new strains. to publish more data in days
The managing director of the German pharmaceutical company BioNTech said he remains confident that the company’s Covid vaccine has been developed in partnership with Pfizerwill be effective against the highly infectious variants of the virus discovered in the UK and South Africa.
“We are confident that based on the mechanism of our vaccine, although there are mutations, we believe that the immune response induced by our vaccine could also treat (a) mutated virus,” said Dr. Ugur Sahin, co-founder and CEO of BioNTech, said CNBC’s Meg Tirrell on Monday.
“Last week we reported another mutation that is present in both the UK and South African variants. This mutation is considered important as it could structurally alter the protein. But it appears that the immune response …